Skip to main content

Want a detailed portfolio tracker?

Oculis (OCS) P/E (2023 - 2026)

Oculis (OCS) P/E from Mar 2, 2023 to Jul 21, 2026. The TTM Oculis (OCS) P/E is -5.52. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Oculis (OCS)

YearP/EChange
2026-5.52-35.91%
2025-8.61+20.91%
2024-7.12+75.98%
2023-4.05N/A

Comparison Oculis (OCS) P/E with competitors

Oculis (OCS) P/E is -5.52.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.08%
ENLVEnlivex Ltd0.07-101.36%
FGENFibroGen Inc0.24-104.35%
CHRSCoherus Biosciences Inc0.85-115.37%
FBIOFortress Biotech Inc0.95-117.19%
ORMPOramed Pharmaceuticals Inc1.50-127.23%
AGENAgenus Inc3.01-154.52%
INVAInnoviva Inc3.15-157.13%
VXRTVaxart Inc3.55-164.30%
CRMDCorMedix Inc3.63-165.73%
CVACCureVac N.V.4.45-180.53%
GLPGGalapagos NV4.86-188.02%
SRPTSarepta Therapeutics Inc4.88-188.44%
ABEOAbeona Therapeutics Inc5.39-197.59%
ABUSArbutus Biopharma Corp5.60-201.36%
ZVRAZevra Therapeutics Inc5.89-206.64%
SPROSpero Therapeutics Inc6.23-212.82%
CGENCompugen Ltd6.31-214.37%
RIGLRigel Pharmaceuticals6.87-224.48%
SLXNSilexion Therapeutics Corp7.30-232.16%
OMEROmeros Corporation9.26-267.72%
AUPHAurinia Pharmaceuticals Inc9.58-273.63%
PLXProtalix BioTherapeutics Inc10.89-297.28%
ACADAcadia Pharmaceuticals Inc11.73-312.45%
TBPHTheravance Biopharma Inc12.26-322.12%
ADMAAdma Biologics Inc12.42-324.95%
HRMYHarmony Biosciences Holdings Inc13.82-350.34%
SABSSAB Biotherapeutics Inc14.14-356.07%
NAGENiagen Bioscience Inc14.82-368.42%
INCYIncyte Corp15.82-386.62%
REGNRegeneron Pharmaceuticals Inc15.86-387.23%
PBYIPuma Biotechnology Inc17.32-413.66%
CPRXCatalyst Pharmaceuticals Inc17.44-415.90%
EXELExelixis Inc17.54-417.69%
TGTXTG Therapeutics Inc18.97-443.56%
MDXGMimedx Group Inc20.55-472.30%
XOMAXOMA Royalty Corp22.87-514.37%
ARGXArgen X SE24.30-540.16%
CTMXCytomX Therapeutics Inc24.82-549.63%
XOMAOXOMA Royalty Corp25.34-559.12%
HALOHalozyme Therapeutics Inc25.62-564.17%
XOMAPXOMA Royalty Corp25.67-565.01%
VRTXVertex Pharmaceuticals Inc27.99-607.12%
RPRXRoyalty Pharma plc - Class A28.69-619.67%
SLNOSoleno Therapeutics Inc29.02-625.61%
ASNDAscendis Pharma A/S30.09-645.00%
LGNDLigand Pharmaceuticals Inc - Class B37.91-786.77%
APLSApellis Pharmaceuticals Inc39.02-806.86%
BMRNBiomarin Pharmaceutical Inc42.21-864.66%
KRYSKrystal Biotech Inc45.34-921.39%
ONCBeiGene Ltd69.54-1359.72%
PHARPharming Group N.V.75.03-1459.08%
TECHBio-Techne Corp101.96-1946.96%
VCELVericel Corp109.92-2091.21%
ALNYAlnylam Pharmaceuticals Inc117.96-2236.92%
GMABGenmab140.29-2641.35%
TLXTelix Pharmaceuticals Ltd162.15-3037.38%
CORTCorcept Therapeutics Inc212.86-3955.89%